Redox-Dependent Copper Carrier Promotes Cellular Copper Uptake and Oxidative Stress-Mediated Apoptosis of Cancer Cells
Source abstract
Abstract
Transportation of exogenous copper ions into cancer cells by copper carriers has gained increasing interest for cancer chemotherapy. We disclosed herein a redox-dependent copper carrier, 2,2'-dithiodipyridine (DPy), which binds copper ions and carries the cargo into cells. The cellular reducing environment cleaved the disulfide bond in DPy to facilitate unloading copper ions. The elevated copper level then elicits oxidative stress and subsequently promotes the reformation of DPy. Further mechanistic studies revealed that the DPy/copper combination predominantly targets the cellular redox-regulating systems, including the thioredoxin system and the glutathione system, to induce the oxidative stress-mediated death of tumor cells. The discovery of DPy as a cleavable and recyclable copper shuttle provides a proof of concept for designing novel biomaterials for copper transportation as potential anticancer agents.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Metal complexes synthesis and properties · Trace Elements in Health · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Life Science and Medicine & Panjin Industrial Technology Institute, Dalian University of Technology, Panjin Campus, Panjin 124221, China
Funding
State Administration of Foreign Experts Affairs · Ministry of Education of the People's Republic of China · National Natural Science Foundation of China · Natural Science Foundation of Gansu Province
References (57)
Show source-provided references
1. 10.1146/annurev.biochem.70.1.67710.1146/annurev.biochem.70.1.677 ↗
2. 10.1016/j.jinorgbio.2011.11.02410.1016/j.jinorgbio.2011.11.024 ↗
3. 10.1080/1093740060075591110.1080/10937400600755911 ↗
4. 10.3109/1071576980906927810.3109/10715769809069278 ↗
5. 10.1016/S0300-483X(03)00159-810.1016/S0300-483X(03)00159-8 ↗
6. 10.1016/j.bmc.2008.09.06810.1016/j.bmc.2008.09.068 ↗
7. 10.1146/annurev-cancerbio-041916-06580810.1146/annurev-cancerbio-041916-065808 ↗
8. 10.1038/nrc380310.1038/nrc3803 ↗
9. 10.1038/nrd280310.1038/nrd2803 ↗
10. 10.1385/BTER:82:1-3:00110.1385/BTER:82:1-3:001 ↗
11. 10.1016/j.ctrv.2008.07.00410.1016/j.ctrv.2008.07.004 ↗
12. 10.1021/cr400135x10.1021/cr400135x ↗
13. 10.1038/nature1318010.1038/nature13180 ↗
14. 10.1021/acsami.5b0648810.1021/acsami.5b06488 ↗
15. 10.1039/C5MT00149H10.1039/C5MT00149H ↗
16. 10.1021/acsami.5b0121410.1021/acsami.5b01214 ↗
17. 10.1021/cb400198p10.1021/cb400198p ↗
18. 10.1039/C4SC00384E10.1039/C4SC00384E ↗
19. 10.1016/j.freeradbiomed.2017.04.02310.1016/j.freeradbiomed.2017.04.023 ↗
20. 10.1016/j.actbio.2016.09.02110.1016/j.actbio.2016.09.021 ↗
21. 10.1158/1535-7163.MCT-12-058010.1158/1535-7163.MCT-12-0580 ↗
22. 10.1126/science.349.6244.12810.1126/science.349.6244.128 ↗
23. 10.1158/0008-5472.CAN-16-119010.1158/0008-5472.CAN-16-1190 ↗
24. 10.1038/nchem.238110.1038/nchem.2381 ↗
25. 10.1021/jm061174f10.1021/jm061174f ↗
26. 10.1074/jbc.M109.02658310.1074/jbc.M109.026583 ↗
27. 10.1021/ja109413c10.1021/ja109413c ↗
28. 10.1021/jm301053a10.1021/jm301053a ↗
29. 10.1021/mp400592n10.1021/mp400592n ↗
30. 10.1021/acs.molpharmaceut.5b0031410.1021/acs.molpharmaceut.5b00314 ↗
31. 10.1021/acs.molpharmaceut.5b0093810.1021/acs.molpharmaceut.5b00938 ↗
32. 10.1016/j.ejmech.2017.10.05810.1016/j.ejmech.2017.10.058 ↗
33. 10.1039/C4CS00026A10.1039/C4CS00026A ↗
34. 10.1021/jm500221p10.1021/jm500221p ↗
35. 10.1074/jbc.M40849420010.1074/jbc.M408494200 ↗
36. 10.1158/0008-5472.CAN-09-302510.1158/0008-5472.CAN-09-3025 ↗
37. 10.1074/jbc.M115.70059110.1074/jbc.M115.700591 ↗
38. 10.1016/j.bbadis.2016.10.01910.1016/j.bbadis.2016.10.019 ↗
39. 10.1021/acs.jmedchem.5b0041010.1021/acs.jmedchem.5b00410 ↗
40. 10.1039/C5FO00097A10.1039/C5FO00097A ↗
41. 10.1016/j.bcp.2015.12.00410.1016/j.bcp.2015.12.004 ↗
42. 10.1002/0471140856.tx0702s0010.1002/0471140856.tx0702s00 ↗
43. 10.1016/j.ejmech.2017.09.02710.1016/j.ejmech.2017.09.027 ↗
44. Freedman J. H. · J. Biol. Chem. · 1989 · 264 · 559810.1016/S0021-9258(18)83589-X ↗
45. 10.1007/s00775-011-0864-x10.1007/s00775-011-0864-x ↗
46. 10.1083/jcb.20180416110.1083/jcb.201804161 ↗
47. 10.1089/ars.2011.436710.1089/ars.2011.4367 ↗
48. 10.1146/annurev.pharmtox.010909.10560010.1146/annurev.pharmtox.010909.105600 ↗
49. 10.1016/j.tips.2017.06.00110.1016/j.tips.2017.06.001 ↗
50. 10.1039/C7MT00327G10.1039/C7MT00327G ↗
51. 10.1046/j.1432-1327.2000.01701.x10.1046/j.1432-1327.2000.01701.x ↗
52. 10.1074/jbc.270.44.2620210.1074/jbc.270.44.26202 ↗
53. 10.1016/j.bcp.2003.10.03110.1016/j.bcp.2003.10.031 ↗
54. 10.1016/j.taap.2008.03.00910.1016/j.taap.2008.03.009 ↗
55. 10.1002/anie.20171091010.1002/anie.201710910 ↗
56. 10.1021/am505799q10.1021/am505799q ↗
57. 10.1039/C7MT00156H10.1039/C7MT00156H ↗